4//SEC Filing
AGILE THERAPEUTICS INC 4
Accession 0000950142-15-000157
CIK 0001261249operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:25 PM ET
Size
31.3 KB
Accession
0000950142-15-000157
Insider Transaction Report
Form 4
Purcell Dennis J
Director10% Owner
Transactions
- Purchase
Common Stock
2015-01-23$5.85/sh+811,966$4,750,001→ 2,983,797 total(indirect: See FN)
AISLING CAPITAL III LP
Director10% Owner
Transactions
- Purchase
Common Stock
2015-01-23$5.85/sh+811,966$4,750,001→ 2,983,797 total(indirect: See FN)
Aisling Capital Partners III LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2015-01-23$5.85/sh+811,966$4,750,001→ 2,983,797 total(indirect: See FN)
SCHIFF ANDREW N
Director
Transactions
- Purchase
Common Stock
2015-01-23$5.85/sh+811,966$4,750,001→ 2,983,797 total(indirect: See FN)
Aisling Capital Partners III LP
Director10% Owner
Transactions
- Purchase
Common Stock
2015-01-23$5.85/sh+811,966$4,750,001→ 2,983,797 total(indirect: See FN)
ELMS STEVE
Director10% Owner
Transactions
- Purchase
Common Stock
2015-01-23$5.85/sh+811,966$4,750,001→ 2,983,797 total(indirect: See FN)
Footnotes (1)
- [F1]The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.
Issuer
AGILE THERAPEUTICS INC
CIK 0001261249
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001261249
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:25 PM ET
- Size
- 31.3 KB